
Arixone S 250mg/125mg Injection
Marketer
Arion Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Arixone S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administer this injection solely under a physician's guidance; strictly adhere to the prescribed dosage schedule. Complete the entire treatment course, regardless of symptom improvement, as premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects to your doctor immediately. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor about all concurrent medications and pre-existing health conditions before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are crucial for optimal recovery. Your doctor might order lab tests and diagnostic imaging to monitor treatment response.
Primary Ingredients of Arixone S 250mg/125mg Injection
There is no text provided to rephrase.
Uses of Arixone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Arixone S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Arixone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Arixone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Arixone S 250mg/125mg Injection works:
Arixone S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Arixone S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Arixone S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials using animal models have revealed minimal or no negative consequences for fetal development; however, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Arixone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Arixone S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Arixone S 250mg/125mg Injection in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
For individuals with severe hepatic impairment, Arixone S 250mg/125mg Injection requires careful administration and potential dosage modification. Medical advice is necessary. Dosage alterations for Arixone S 250mg/125mg Injection are generally unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Arixone S 250mg/125mg Injection :
Should you inadvertently skip a dose of Arixone S 250mg/125mg Injection, seek medical advice from your physician.
Facts to Know About Arixone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
